Horaizon Spółka z Ograniczoną Odpowiedzialnością (KRS 0000286026, NIP 6792945528) is a Polish company, headquartered in Skawina, Małopolskie voivodeship. Horaizon operates in: Scientific research and development (PKD 72.10.Z). Industry: Research and development. The company has been listed in the National Court Register since August 6, 2007. Horaizon's most recently reported net revenue was 24.0 K PLN for 2024.
Negative equity
Negative equity in 2 of 7 available reporting years.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Horaizon
Identity
- Name
- Horaizon Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- August 6, 2007
- Registry status as of
- July 14, 2026
- Latest entry
- July 14, 2026
- Founding act
- 01.07.2009 , NOTARIUSZ TOMASZ KOT , KANCELARIA NOTARIALNA W KRAKOWIE , REP. A NR 9382/2009 - ZMIANA § 7
Articles of association history (7)
- AKT NOTARIALNY Z DNIA 23 LIPCA 2007 ROKU ASESOR NOTARIALNY LESZEK SOJKA ZASTĘPCA NOTARIUSZA TOMASZA KOTA KANCELARIA NOTARIALNA W KRAKOWIE PRZY UL. TOPOLOWEJ 11 REPERTORIUM A NR 7051/2007
- July 1, 2009: 01.07.2009 , NOTARIUSZ TOMASZ KOT , KANCELARIA NOTARIALNA W KRAKOWIE , REP. A NR 9382/2009 - ZMIANA § 7
- 15-02-2010, REP. A NR 1696/2010, NOTARIUSZ TOMASZ KOT Z KANCELARII NOTARIALNEJ W KRAKOWIE, ZMIANA § 25 UMOWY SPÓŁKI
- March 16, 2011: 16.03.2011R REP.A NR 2151/2011,NOTARIUSZ TOMASZ KOT Z KANCELARII NOTARIALNEJ W KRAKOWIE-ZMIANA § 3 UMOWY SPÓŁKI ORAZ DODANIE DO § 16 UST.5
- January 25, 2017: 25.01.2017 REP A NR 214/2017 NOTARIUSZ JUSTYNA TUSZYŃSKA KANCELARIA NOTARIALNA W KRAKOWIE ZMIENIONO: § 7, § 11 UST. 2, § 18, § 19 PKT. 10, § 23 UST. 4, § 24 UST. 3 , § 25, SKREŚLONO: § 19 PKT. 16 DODANO: § 8 UST. 4
- June 18, 2019: 18.06.2019R. - ZMIANA UMOWY W § 2 AKT NOTARIALNY SPORZĄDZONY PRZEZ NOTARIUSZA JUSTYNĘ TUSZYŃSKĄ, Z KAN. NOT. W KRAKOWIE REP. A NR 5957/2019.
- 20 LUTEGO 2026 R., REPERTORIUM A NR 707/2026, NOTARIUSZ JUSTYNA TUSZYŃSKA, KANCELARIA NOTARIALNA W KRAKOWIE, UCHYLENIE DOTYCHCZASOWEGO BRZMIENIA UMOWY SPÓŁKI I PRZYJĘCIE NOWEGO BRZMIENIA UMOWY SPÓŁKI.
Activities
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- KRAKOWSKA, 43, 32-050, SKAWINA, POLSKA
- Voivodeship
- MAŁOPOLSKIE
- District
- KRAKOWSKI
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-37853-97501-VGFRG-28
Risk and payment profile - Horaizon
Credibility rating
72.3 / 100
Good credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
2
2/19 yrs
Board changes
4
4/19 yrs
PKD changes
3
3/19 yrs
Name changes
2
2/19 yrs
Data from 19 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: B (72/100)
Trend: improving (+15.1 pts/year)
High payment credibility - the company's financial condition is good and the risk of cooperating with it is low.
Trade credit limit history
Standard limit from 2018–2024
Current: 4.2 K PLN
Safe: 2.7 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Horaizon
Founded
August 6, 2007
18 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
SKAWINA
MAŁOPOLSKIE
Primary PKD
72.10.Z
Scientific research and development
Share capital
50.0 K PLN
50 shares total
Shareholders
2
shareholders
Board
2 people
Filed years
7 years
2018–2024 · profitable: 2/7
Registry entries
42
latest: July 14, 2026
Risk signals
Revenue
24.0 K PLN
2024
Net profit
6.8 K PLN
2024
Assets
70.7 K PLN
2024
Equity
69.9 K PLN
2024
Valuation
39.3 K PLN
Medium confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Horaizon.
No ratings
Related articles
News
Bioceltix in the final EMA dialogue phase: BCX-CM-J could become Europe's first veterinary cell-therapy drug for dogs
Wrocław-based Bioceltix S.A. (KRS 0000744521) entered Q2 2026 in the final EMA dialogue phase on BCX-CM-J – potentially Europe's first veterinary cell-therapy drug based on mesenchymal stem cells, for dogs with osteoarthritis. Responses to the EMA's final questions are due in May 2026; a CVMP recommendation and marketing authorisation are possible in Q3/Q4 2026. A pre-commercial biotech: it closed 2024 with a PLN 14.9m loss on zero revenue and PLN 33.6m of cash at year-end. Trigon DM maintains a buy rating with a PLN 127.2 price target.
News
Captor Therapeutics: PLN 36m of cash at 30 September 2025, runway to mid-2026 – clinical data versus the cash clock
Wrocław-based Captor Therapeutics S.A. (KRS 0000756383) – a pre-commercial biotech specialising in targeted protein degradation (TPD) – closed Q3 2025 with PLN 36m of cash and grants securing funding to mid-2026. CT-01 (hepatocellular carcinoma) entered Phase I, with the first patient dosed at the Barcelona Clinic Liver Cancer. CT-03, an MCL-1 degrader, is close to clinical entry. Without a new R&D partnership or share issue in 2026, the company will need additional financing.
